Clinical Trial Update: Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC [Phase 1]

View source ↗

Summary

Phase 1 study completed to assess safety, tolerability, and pharmacokinetics of HPN-07 alone and with N-acetylcysteine in individuals with hearing loss, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss
• Noise-induced Hearing Loss
• Sensorineural Hearing Loss

Drugs mentioned

• HPN-07 (HPN-07)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Otologic Pharmaceutics, Inc. | Conditions: Hearing Loss, Sensorineural Hearing Loss | Phase 1 | Status: COMPLETED